Aug 17 (Reuters) - Warner Chilcott Plc said German drugmaker Bayer Pharma
AG filed a complaint against the U.S. pharmaceutical company, alleging that Warner's oral contraceptive drug Lo Loestrin FE infringes a Bayer patent.
According to the complaint filed in a U.S. district court, Bayer is seeking an injunction on the product along with unspecified monetary damages, Warner said in a filing.
New Jersey-based Warner said it would defend the litigation as it believes the complaint lacks merit.
Bayer could not immediately be reached for comment.
Warner Chilcott's shares were a cent down at $16.98 in trading after the bell. They closed at $16.99 earlier on Friday on the Nasdaq.
(Reporting by Prateek Kumar in Bangalore; Editing by Anil D'Silva) Keywords: WARNERCHILCOTT BAYER/PATENT
(firstname.lastname@example.org, within U.S. +1 646 223 8780)(outside U.S. +91 80 4135 6385, Reuters messaging: email@example.com)
COPYRIGHT Copyright Thomson Reuters 2012. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.